Learn More
HER2 Trastuzumab Biosimilar anti-Human, Unconjugated, Clone: Trastuzumab.rMAb (also known as Trastuzumab Biosimilar), BD Phrmingen™
Shop All BD Biosciences ProductsDescription
Specifications
Specifications
| Antigen | HER2 Trastuzumab Biosimilar |
| Applications | Flow Cytometry, Inhibition Assays |
| Classification | Monoclonal |
| Clone | Trastuzumab.rMAb (also known as Trastuzumab Biosimilar) |
| Concentration | 1.0 mg/mL |
| Conjugate | Unconjugated |
| Formulation | No azide/low endotoxin: Aqueous buffered solution containing no preservative, 0.2 μm sterile filtered. Endotoxin level is ≤0.01 EU/μg (≤0.001 ng/μg) of protein as determined by the LAL assay. |
| Gene Alias | ERBB2; proto-oncogene c-ErbB-2; HER-2; HER2; HER-2/neu; NEU; CD340 |
| Immunogen | A431 Cell Line Expressing EGFR |
| Purification Method | Affinity Chromatography |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.